Objective The aims of this paper were to identify, characterise and explain clinician factors
that shape decision-making around antidepressant discontinuation in UK primary care …

AIMS AND METHOD: Withdrawal symptoms are associated with cessation of all
antidepressants but particularly paroxetine and venlafaxine. We aimed to examine rates of …

Background: Protracted withdrawal syndrome (PWS) after stopping antidepressants
(frequently also referred to as post-acute withdrawal syndrome or PAWS) has been …

Objective To explore patient and health professional views and experiences of
antidepressant treatment with particular focus on barriers and facilitators to discontinuing …

Scholten et al.[1] reported on the first randomized controlled trial that attempted to prevent
relapse in patients with remitted anxiety disorder who discontinued antidepressant drugs …

Strong evidence supports the existence of a discontinuation syndrome following the
withdrawal of antidepressant medication, particularly second-generation antidepressants …

Background: Long-term antidepressant use has increased exponentially, though this is not
always according to guidelines. Our previous randomized controlled trial (RCT) showed that …

More than 10% of adults are prescribed antidepressants annually in some countries. Recent
increases in prescribing can be explained more by repeat prescriptions than new patients …

Background Antidepressant discontinuation symptoms are becoming an increasingly
important part of clinical practice, but the incidence of antidepressant discontinuation …

Objective: The purpose of the survey was to better understand the experiences of people
who attempt antipsychotic discontinuation. Method: A multiple-choice and short-answer …